Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in autoimmune recurrent pregnancy loss refractory to aspirin and heparin
PACTR202104858485905Unknown
- Sponsor
- Ain Shams University Maternity Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of hydroxychloroquine in recurrent miscarriage (RPL) and antiphospholipid syndrome (APS) (2 arms), sponsored by Ain Shams University Maternity Hospital. Primary endpoint: Live birth rate. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
recurrent miscarriage (RPL)antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on PACTR202104858485905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202104858485905.